Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

Patricio López-Jaramillo email, Lina P Pradilla email, Vicente Lahera email, Federico A Silva Sieger email, Christian F Rueda-Clausen email and Gustavo A Márquez email

Trials 2006, 7:28doi:10.1186/1745-6215-7-28

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.